A Leading Zantac Law Firm Helping People Nationwide.
Led by a Former FBI Special Agent
Cancer Causing NDMA Found in Zantac
Brown, LLC has recovered millions of dollars for clients who were the victims of bad products like Zantac
Past results don’t guarantee future success
The following types of cancer may be linked to Zantac usage:
Throat, Nose or Esophageal Cancer
Testicular Cancer in children (exposed in the womb through the mother)
How could Zantac cause cancer? I thought it was safe and FDA approved?
The FDA warned about Zantac (ranitidine hydrochloride) in late 2019 after it was discovered that cancer causing as N-nitrosodimethylamine “NDMA” was discovered in it at a level several thousand times greater than the FDA limits! Zantac was touted for treating acid reflux, heartburn, ulcers, gastroesophageal reflux disease (GERD), Barrett’s esophagus, stomach acid and more.
What did the makers Sanofi and Boehringer know about the Zantac Cancer link and when did they know it?
For years Sanofi and Boehringer Ingelheim may have known about the link between Zantac and NDMA and may have concealed that link from its users to become a Billion Dollar Product. Many companies put profits before people and the Zantac lawsuits will focus on the conduct of the companies in concealing the NDMA Zantac link.
How do I join the Zantac Lawsuit?
It’s never to early to hire a Zantac lawyer to learn about what your rights are. There are statutes of limitations and even if you didn’t know about the NDMA link until now, some courts may start running that statute when the cancer was diagnosed, and others may toll it until you knew about the link. If you used Zantac and were diagnosed with cancer you need to speak with a lawyer right away. The Zantac lawyers at Brown, LLC are standing by at (877) 561-0000 and can educate you about your rights and file your case to try and help you obtain compensation. Brown, LLC only handles Zantac lawsuits on contingency, meaning we’re only paid if we win your case.
See If You Qualify for the Zantac Lawsuit!
Fill out the form below and our team will reach out to you.
FREQUENTLY ASKED QUESTIONS – ZANTAC CANCER LINK LAWSUIT
No. This is not a class action. This is a lawsuit against the makers of Zantac to hold them accountable for suppressing the link between Zantac and NDMA which causes cancer. When multiple people are injured by the same product then the case is known as a mass tort. Mass torts are different than class actions, because each individual injured is entitled to their own day in Court. Also, if there is a Zantac settlement then it will classically settle in the mass tort world as an injury case with the individuals who were injured receiving the lion share of the proceeds from the settlement.
- The following cancers may be related to Zantac usage:
- Zantac related Gastric Cancer
- Zantac related Liver Cancer
- Zantac related Bladder Cancer
- Zantac related Kidney Cancer
- Zantac related Lung Cancer
- Zantac related Pancreatic Cancer
- Zantac related Colon Cancer
- Zantac related Rectal Cancer
- Zantac related Colorectal Cancer
- Zantac related Stomach Cancer
- Zantac related Throat, Nose or Esophageal Cancer
- Zantac related Testicular Cancer
- Zantac related Testicular Cancer in children exposed in the womb through the mother
- Zantac related Brain Cancer
- Zantac related Prostate Cancer
The proof that Zantac causes cancer goes back to early school logic. NDMA N-nitrosodimethylamine is a known carcinogen – that is it is known to cause cancer. Zantac contains NDMA (in levels up to several thousand times greater than permitted by the FDA). Since Zantac has too much of cancer causing agent NDMA in it, the Zantac, like its component NDMA, causes cancer.
Zantac consists of the active ingredient ranitidine hcl which metabolizes into NDMA. The FDA allows products to market that test at less than 100 nanograms of NDMA. Testing in 2019 of Zantac has shown more than several thousand times the legal limit of NDMA. Either they didn’t know of the metabolization rates, or they knew and concealed it. In either event, Sanofi and Boehringer Ingelheim must be held accountable.
An online pharmacy who conducts random tests on batches of products before it releases it to consumers discovered the link in 2019. As a credit to the online pharmacy Valisure, it alerted the FDA to the Zantac NDMA link. Sometimes the government is the last to know, but in this case, it’s worse – it’s the consumers who have been ingesting a potential carcinogen perhaps for years.
There have been many recalls of Zantac over this including the generic makers such as GSK and Sandoz offering refunds and Walgreens and CVS pulling it from the shelves. Even Sanofi recalled certain batches, presumably (as of this writing) to assert that this is a batch issue, not a widespread issue, but there’s other indications this is not in isolation. In Australia, they recalled Zantac finding high levels of NDMA. So the issue worldwide with the product, not just a few batches.
As of this writing in the latter part of 2019 there is no Zantac settlement, nor is there a global Zantac settlement in the works. It takes time to hold drug companies accountable for their conduct and they may try to argue many defenses including family history of cancer, or that only some of their product had too much NDMA, not all of it. Still the Zantac lawyers at Brown, LLC will spend our time and money helping victims of this bad product.
The active ingredient ranitidine in Zantac can be found in the following non-exhaustive list:
Zantac 150 Tablets
Zantac 150 Maximum Strength Cool Mint
Heartburn Relief (ranitidine)
Acid Control (ranitidine)
Acid Reducer (ranitidine)
If you suspect cancer you should speak with your doctor immediately. Anyone with long term Zantac usage should also confront one’s physician regarding the consequences of taking the product for extended periods of time and be super vigilant to ensure that you are cancer free.
If you were unfortunately diagnosed with cancer after taking Zantac, you should speak with our Zantac law firm right away at (877) 561-0000. Keep any and all proof of purchase of the Zantac. DO NOT THROW THE ZANTAC OUT (as that is proof of use). If you seek a refund via the recall, speak with an attorney first as the product in your possession may have to be tested for NDMA, especially if you’ve already been diagnosed with cancer. The lawyers at Brown, LLC have worked championing people’s rights against the drug manufacturers for over a decade. The head of the firm was a former FBI Special Agent who focuses on holding drug companies accountable for pharmaceutical injuries like this and was the first attorney in the country to file a battery of cases against a company that resulted in a hundred million dollar settlement. There’s no guarantee of success, but what happened isn’t right. Our firm is willing to put our money and our time fighting for your rights. If you were diagnosed with cancer after exposure to Zantac call our Zantac litigation team at (877) 561-0000 right away to learn your rights.
100 Million Dollar Settlement Fund for Women Injured by Nuvaring
Jason T. Brown was the first attorney in the country to file a battery of cases on behalf of women who sustained blood clots, such as deep vein thrombosis, pulmonary embolisms, strokes and death from Nuvaring. Jason T. Brown’s prior firm was on the PSC (Plaintiff Steering Committee) and served as liaison counsel in the state mass tort action. The firm is no longer accepting new cases.
Tens of Millions in Settlements for Mass Tort Injuries and Class Actions
$7 Million Plus Settlement for Consumer Fraud
$7 Million Dollar Commercial Litigation Settlement
Millions in Settlements for Women Injured by Yaz, Yasmin, Ocella and Gianvi
Women who sustained blood clots from Yaz, Yasmin, Ocella and Gianvi received and continue to receive compensation for their injuries. Compensable injuries include Pulmonary Embolisms (PE), Deep-Vein Thrombosis (DVT), Strokes and Death. The firm is still investigating and accepting cases.
Nationwide $3.5 Million Settlement for Wage & Hour Class Action Case
Case brought on behalf of at home call center workers who were not paid for all their time worked including boot up time, technical time and other time. Workers were told by the company that boot up time which lasted 15 minutes or more was not paid because it was considered their commute to work. Fair Labor Standards Act (FLSA).
$3.2 Million Settlement for Wage & Hour Class Action Case
Case brought on behalf of workers who were misclassified as salaried exempt from overtime. The employer led employees to believe that they had to work unlimited hours over 40 without overtime compensation even though based on their job duties it was alleged they were entitled to overtime pay.
$2.4 Million Dollar Settlement for Wage & Hour Class Action
Lawsuit was brought as a class action on behalf of workers who worked in excess of 40 hours a week and were not paid overtime. The employer was forcing them to work “off the clock” for those hours and failed to pay proper overtime compensation.
$2 Million Dollar Settlement for False Claims Act (Whistleblower Case)
“$2 Million Dollar False Claims Act (FCA) Settlement – Unnecessary Services”
A case against GenomeDx was brought alleging violations of the False Claims Act (FCA) and the California Insurance Claims Fraud Prevention Act regarding unnecessary services such as the testing of tissues that did not need to be tested. The case resulted in a $350,000 whistleblower award.
$2 Million Dollar Settlement for Truck Accident Victim
Our firm was Of Counsel to a serious truck accident case involving a trucking accident with multiple injuries.
Nationwide $1.3 Million Judgment against Future Income Payments and Scott Kohn for Consumer Fraud
Scott Kohn and Future Income Payments conspired to defraud veterans out of their hard earned pensions by offering them loans at loanshark rates and claiming it was a “purchase” not a loan.
$1.7 Million Dollar Settlement for Wage & Hour Case
Misclassified employees under the FLSA were not paid overtime for hours worked in excess of 40. Due to a confidentiality agreement specific details are intentionally omitted.
Judgment with Maximum Damages for Employment Litigation
Judgment for misclassification under the FLSA including maximum damages under State and Federal Laws, plus an incentive fee for the lead plaintiff with attorney fees paid separately. The case involved a worker who was paid a day rate regardless of the amount of hours worked per day and per week.
Class Action Jury Trial
Workers alleged that they were misclassified according to their job duties. The Defendant claimed an administrative exemption under the FLSA and state law. Misclassification cases under the FLSA are the cases most often tried due to non-monetary considerations. Jury Trial lasted three weeks. Settlement offered in lieu of appeal.
Acquittal at Trial
Despite videotaped evidence that the prosecutor alleged incriminated the defendant, Mr. Brown was able to obtain an acquittal at trial for his client. Please note, that while we, the Brown, LLC will provide consultations in defense matters, the firm spends most of its time litigating complex litigation such as class actions, mass torts and catastrophic injuries.
Judgment with Maximum Damages for Wage & Hour Dispute
Wage & Hour dispute on behalf of hourly employees who were not paid time and a half for hours in excess of 40. Employees were granted double damages for all their time with attorney fees and costs paid separately.
Million Dollar Settlement for Wage & Hour Class Action Case
Workers were compelled to come into work 15 minutes early to set up, but were not paid for their set up time. Gap issues aside, workers received double damages for the time worked for 3 years’ worth of pay with attorney fees paid separately.
This is a non-exhaustive list of prior results and successes of Jason T. Brown and the Brown, LLC. Past results do not guarantee a similar outcome.
For more information about each award see Awards & Accolades – No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
Results may vary depending on your particular facts and legal circumstances.